Medtronic’s most recent trend suggests a bullish bias. One trading opportunity on Medtronic is a Bull Put Spread using a strike $55.00 short put and a strike $50.00 long put offers a potential 7.07% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $55.00 by expiration. The full premium credit of $0.33 would be kept by the premium seller. The risk of $4.67 would be incurred if the stock dropped below the $50.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Medtronic is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Medtronic is bullish.
The RSI indicator is at 72.8 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Medtronic
Boston Scientific Pays $30 Million in Heart-Device Accord
Thu, 17 Oct 2013 18:41:47 GMT
Bloomberg – Boston Scientific Corp. agreed to pay $30 million to settle a whistle-blower lawsuit alleging the company’s Guidant unit knowingly sold defective heart devices, U.S. officials said.
InPlay: Medtronic to unveil CoreValvue U.S. pivotal trial results at TCT 2013
Thu, 17 Oct 2013 16:04:09 GMT
Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013
Thu, 17 Oct 2013 16:01:01 GMT
Thomson Reuters ONE – Late Breaking Clinical Trial Features the First U.S. Data of Novel Self-Expanding Transcatheter Valve at Premier Interventional Cardiology Meeting Other Late-Breakers Feature New Clinical Data on Endeavor …
Health care companies bit the bullet up front: Pro
Wed, 16 Oct 2013 21:40:00 GMT
CNBC – Discussing the “side effects” of the medical device tax, with Mike Weinstein, JPMorgan. He says investors should look for health care companies with improving fundamentals.
St. Jude Beats Q3 Estimates Amid Search For Growth
Wed, 16 Oct 2013 21:19:00 GMT
Investor’s Business Daily – St. Jude Beats Q3 Estimates Amid Search For Growth
Also on Market Tamer…
Follow Us on Facebook